Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Strikes Agreement for Cheaper Reagents for New York Biomedicine

NEW YORK, Nov. 14-AMDeC Foundation, New York's biomedical umbrella organization, has arranged a discounted supplier relationship with PerkinElmer for microarray reagents.


Under the arrangement, PerkinElmer will supply non-radioactive labeled nucleotide analogs, including cyanine- and biotin-labeled nucleotides, to the 39 AMDeC member institutions at "significant" savings.


The company would not provide specific or ballpark figures on the discount.


AMDeC (the "Academic Medical Development Corporation") promotes biomedical research in New York. Its members include Cold Spring Harbor Labs, the State University of New York at Buffalo, Rockefeller University, Memorial Sloan-Kettering Cancer Center, and other institutes and hospitals.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.